Atrial Fibrillation Screening and Education Study
Evaluation of a Community-Placed Atrial Fibrillation Screening and Education Program
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Descripción detallada
Background/significance: Atrial fibrillation (AF) is a global epidemic that accounts for 15%-20% of 795,000 strokes occurring annually in the US, at a cost of $3.2 billion per year. Atrial fibrillation-related stroke will rise with the aging population and places enormous strain on healthcare resources and quality of life; yet they are highly preventable, by early detection of AF. Timely treatment reduces AF-related stroke risk by 68%, yet treatment is often delayed because people may not recognize the symptoms of AF or may be asymptomatic. Given the number of people at risk for development of AF and the dire consequences of untreated AF, efforts to promote early detection of AF through proactive screening of older adults at risk for AF have been successfully undertaken in Europe and Australia. However, little is known about the outcomes of conducting programs to screen for and educate people about AF in community settings in the US.
Purpose: The purpose of this descriptive pragmatic study to evaluate the outcomes of a community placed AF screening and education program. Primary outcomes include feasibility, number of participants who screen positive for AF, and changes in participants' Knowledge, Attitudes, and Beliefs about Atrial Fibrillation Self-Monitoring (KABAF-SM) scores from baseline to two-weeks after enrollment.
Methods: Up to 250-participants who have at least two risk factors for developing AF and have no previous diagnosis of AF will be recruited from Midwest community settings and will be screened for AF using a mobile ECG recorder and will receive written information sheet about AF. A portion (up to 125) of those 250 participants will be invited to complete the KABAF-SM at baseline and 2-weeks after enrollment. Participants will have the option to participate in a variety of AF educational activities to reinforce and enhance the written information. Participants will be surveyed about their perceptions of the educational program after the screening and participating in the educational activities.
Evaluation methods: Descriptive statistics will be used to analyze feasibility (enrollment numbers, participants perception of the value of the educational activities, time required for study procedures,and AF detection.T-tests will be used to test for differences between KABAF-SM baseline and two-week scores for those who completed the KABAF-SM.
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Minnesota
-
Rochester, Minnesota, Estados Unidos, 55905
- Mayo Clinic in Rochester
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Descripción
Inclusion :
Any two of the following:
- Hypertension
- Diabetes
- Sleep apnea
- Obesity
- Age > 75 years
- Peripheral arterial disease
- Female
Exclusion :
- Previous diagnosis of atrial fibrillation or atrial flutter
- Uncompensated visual impairment
- Uncompensated hearing impairment
- Inability to communicate verbally in English
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Poner en pantalla
- Asignación: N / A
- Modelo Intervencionista: Asignación de un solo grupo
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Otro: AF awareness education
AF awareness education face to face
|
Participants will receive education about a description of AF, complications, recognition of signs and symptoms of AF, pulse taking, and how to recognize an irregular pulse
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Feasibility-number enrolled
Periodo de tiempo: 5 months
|
number of participants enrolled
|
5 months
|
|
Feasibility-time required for study procedure
Periodo de tiempo: 5 months
|
Number of minutes require to perform mobile ECG
|
5 months
|
|
Participants' perception of the usefulness of the Learning Station activities
Periodo de tiempo: 5 months
|
The outcome will be measured by the Participant Perception of Learning Station Activities survey.
This survey is an investigator developed 9-item Survey that asks participants to rate how useful learning activities were to increase their knowledge about atrial fibrillation and to what extent their knowledge about atrial fibrillation has increased after participating in the Learning Station activities.
Psychometric testing has not been performed on this survey.
|
5 months
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Change in knowledge attitude, and beliefs scores about AF self monitoring from baseline
Periodo de tiempo: 5 months
|
Knowledge, attitudes, beliefs about self-monitoring for AF signs and symptoms will be measured by the Knowledge Attitudes and Beliefs about Atrial Fibrillation Self-Monitoring (KABAF-SM) instrument.The KABAF-SM is a 40-item instrument that measures knowledge of AF symptoms (8 items yes/no response, score range 0-8); symptoms not related to AF (6 items yes/no response, score range 0-6); and Likert- responses items (strongly disagree-1 to strongly agree-4) for beliefs about the participant's risk for developing AF(5 items), seriousness of AF,(4 items) benefits (5 items), and barriers (5 items) to monitoring for signs and symptoms of AF.
Total score range for the Likert items is 14-56.
Perceived confidence is measured by 7 items, rated from 0-10 (score range, 0-70) for ability to self-monitor for signs and symptoms of AF.
Higher scores reflect more knowledge and more accurate beliefs and positive attitudes toward self-monitoring.
|
5 months
|
|
Number of cases of atrial fibrillation detected with portable ECG
Periodo de tiempo: 5 months
|
The Alive Cor portable ECG recorder will be used to detect atrial fibrillation.
The device displays the participants rhythm as normal sinus, possible or probable atrial fibrillation, or unable to analyze
|
5 months
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Investigadores
- Investigador principal: Pamela J McCabe, Mayo Clinic
Publicaciones y enlaces útiles
Enlaces Útiles
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- 17-005031
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .
Ensayos clínicos sobre Fibrilación auricular
-
Memorial Sloan Kettering Cancer CenterAmerican Heart AssociationReclutamiento"Pacientes adultos con cáncer" | Right Atrial ClotEstados Unidos
-
The Second Affiliated Hospital of Chongqing Medical...TerminadoFibrilación auricular | Hipertensión,Esencial | Dilatación atrial izquierdaPorcelana
-
Region SkaneTerminadoFibrilación auricular | Dilatación atrial izquierdaSuecia
-
Parc de Salut MarReclutamientoFibrilación auricular paroxística | Accidente cerebrovascular criptogénico | Trastorno del ritmo cardíaco | Dilatación atrial izquierdaEspaña
-
Wake Forest University Health SciencesNational Heart, Lung, and Blood Institute (NHLBI)ReclutamientoEnfermedades Renales | Hipertensión | Obesidad Pediátrica | Proteinuria | Albuminuria | Lesión renal | Trastornos de la presión arterial | Disfunción autonómica | Enfermedad renal pediátrica | Disfunción Ventricular Izquierda | Hipertrofia del ventrículo izquierdo | Disfunción renal | Desequilibrio autonómico | Disfunción... y otras condicionesEstados Unidos
Ensayos clínicos sobre AF awareness education
-
Yale UniversityNational Institute on Drug Abuse (NIDA)TerminadoTrastornos por consumo de drogas | Diagnóstico psiquiátrico | Diagnóstico Dual (Psiquiatría)Estados Unidos
-
Tarsus UniversityTerminadoEducación EnfermeríaPavo
-
Chia-Tzu LineTerminadoDiabetes mellitus tipo 2 (DM2) | Pacientes diabéticos, autocuidado, basada en inteligencia artificial, autoeficaciaPorcelana
-
State University of New York at BuffaloActivo, no reclutando
-
Yonsei UniversityReclutamientoFibrilación auricular pacientes tratados con el sistema PFA Farapulse ™Corea del Sur
-
Yonsei UniversityAún no reclutandoFibrilación auricular en el tratamiento de apixabanCorea, república de
-
University of Texas at AustinReclutamientoPrediabetes / Diabetes tipo 2Estados Unidos
-
University of SheffieldUniversity of Liverpool; University of Manchester; University of MelbourneActivo, no reclutandoDesarrollo del lenguajeReino Unido